TARDBP and Alzheimer disease: Our study provides the first estimate of the extent of TDP-43 brain pathology in ageing, ALS, and AD using an RNA aptamer with greater sensitivity compared to previous antibody-only approaches, revealing a hitherto underestimated extent of brain TDP-43 in this disease.